TSX-V:VM - CA92918C1014 - Common Stock
The current stock price of VM.CA is 0.165 CAD. In the past month the price decreased by -5.71%. In the past year, price increased by 230%.
Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The company focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
VOYAGEUR PHARMACEUTICALS LTD
Dome Tower 800, 333 7 Ave. S.W.
Calgary ALBERTA T2G 2B3 CA
CEO: Brent Willis
Employees: 0
Phone: 14039235944
The current stock price of VM.CA is 0.165 CAD.
The exchange symbol of VOYAGEUR PHARMACEUTICALS LTD is VM and it is listed on the TSX Venture Exchange exchange.
VM.CA stock is listed on the TSX Venture Exchange exchange.
VOYAGEUR PHARMACEUTICALS LTD (VM.CA) has a market capitalization of 28.16M CAD. This makes VM.CA a Nano Cap stock.
VOYAGEUR PHARMACEUTICALS LTD (VM.CA) currently has 0 employees.
VOYAGEUR PHARMACEUTICALS LTD (VM.CA) has a support level at 0.16 and a resistance level at 0.17. Check the full technical report for a detailed analysis of VM.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VM.CA does not pay a dividend.
VOYAGEUR PHARMACEUTICALS LTD (VM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
ChartMill assigns a technical rating of 3 / 10 to VM.CA. When comparing the yearly performance of all stocks, VM.CA is one of the better performing stocks in the market, outperforming 94.25% of all stocks.
Over the last trailing twelve months VM.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -22.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -73.87% | ||
ROE | -238.54% | ||
Debt/Equity | 0.04 |